What's new

Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 35, Status: Authorised

Mar 28, 2025 - 15:28
 0
Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 35, Status: Authorised
Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 35, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date...

Next Article

Crealis announces arrival of new CEO

Related Posts

Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0

Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Human medicines European public assessment report (EPAR): Ryjunea, Status: Opinion

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0